Recently, studies also reported that ALKBH5 suppressed bladder cancer cell proliferation and induced sensitivity to cisplatin-based chemotherapy through m6A-CK2a-mediated glycolysis (39). Here, ALKBH5 is linked to urinary bladder carcinoma.